Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P-glycoprotein expression in soft-tissue sarcomas

H Nakanishi1, A Myoui, T Ochi

  • 1Department of Pathology, Osaka University Medical School, Japan.

Journal of Cancer Research and Clinical Oncology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Journal of Artificial Organs 2019: the year in review : Journal of Artificial Organs Editorial Committee.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2020
Same author

Journal of Artificial Organs 2018: the year in review : Journal of Artificial Organs Editorial Committee.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2019
Same author

Journal of Artificial Organs 2017: the year in review : Journal of Artificial Organs Editorial Committee.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2018
Same author

Journal of Artificial Organs 2016: the year in review : Journal of Artificial Organs Editorial Committee.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2017
Same author

Journal of Artificial Organs 2015: the year in review : Journal of Artificial Organs Editorial Committee.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2016
Same author

Journal of Artificial Organs 2014: the year in review.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2015

Multidrug resistance (MDR) in cancer is often caused by P-glycoprotein (P-gp). High-grade soft-tissue sarcomas show higher P-gp expression, indicating a poorer prognosis and guiding treatment selection.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Multidrug resistance (MDR) is a significant challenge in cancer chemotherapy.
  • P-glycoprotein (P-gp), a product of the MDR1 gene, acts as a transmembrane pump, effluxing chemotherapeutic agents from cells.
  • Understanding P-gp expression is crucial for predicting treatment response in neoplastic diseases.

Purpose of the Study:

  • To investigate the expression of P-glycoprotein (P-gp) in soft-tissue sarcomas.
  • To correlate P-gp expression levels with histological grade and tumor type.
  • To evaluate the prognostic significance of P-gp expression in soft-tissue sarcomas.

Main Methods:

  • Immunohistochemical analysis of P-gp expression using JSB-1 and C-219 monoclonal antibodies.

Related Experiment Videos

  • Study conducted on paraffin-embedded tissue sections from 55 soft-tissue sarcoma patients.
  • Histological grading based on established criteria.
  • Main Results:

    • P-gp expression was detected in 62% (34 out of 55) of soft-tissue sarcoma cases.
    • A significant correlation was found between high-grade tumors and increased P-gp expression (90% vs. 46% in lower grades, P < 0.005).
    • P-gp-positive tumors, particularly high- and intermediate-grade, exhibited a less favorable prognosis compared to P-gp-negative tumors.

    Conclusions:

    • P-glycoprotein (P-gp) expression is prevalent in soft-tissue sarcomas and is significantly associated with higher tumor grades.
    • P-gp expression serves as a potential indicator of a less favorable prognosis in these tumors.
    • Assessing P-gp expression may aid in selecting optimal therapeutic strategies for cancer patients.